Attached files

file filename
EX-31.2 - CERTIFICATION PURSUANT TO RULE 13A-14(A) OF THE SECURITIES EXCHANGE ACT OF 1934 - MediXall Group, Inc.mdxl_ex31z2.htm
EX-31.1 - CERTIFICATION PURSUANT TO RULE 13A-14(A) OF THE SECURITIES EXCHANGE ACT OF 1934 - MediXall Group, Inc.mdxl_ex31z1.htm
10-K - ANNUAL REPORT - MediXall Group, Inc.mdxl_10k.htm

EXHIBIT 32.1


CERTIFICATION PURSUANT TO 18 U.S.C. 1350

AS ADOPTED PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002


In connection with the Annual Report of MediXall Group Inc. (the “Company”) on Form 10-K for the year ended December 31, 2019 as filed with the Securities and Exchange Commission (the “Report”), I, Neil Swartz, Interim Chief Executive Officer of the Company, and I, Timothy S. Hart, Chief Financial Officer of the Company, do hereby certify, pursuant to 18 U.S.C. § 1350, as adopted pursuant to § 906 of the Sarbanes-Oxley Act of 2002, that:

  

1.

The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934, as amended, and

  

2.

The information contained in the Report fairly presents, in all material respects, the financial conditions and results of operations of the Company.

  

  


Date:      May 14, 2020

  

/s/ Neil Swartz

Neil Swartz, Interim Chief Executive Officer
(Principal Executive Officer)


  

Date:      May 14, 2020

  

/s/ Timothy S. Hart

Timothy S. Hart, Chief Financial Officer
(Principal Financial Officer)

  

A signed original of this written statement required by Section 906, or other document authenticating, acknowledging, or otherwise adopting the signatures that appear in typed form within the electronic version of this written statement has been provided to the Company and will be retained by the Company and furnished to the Securities and Exchange Commission or its staff upon request.